Skip to main content
Caplight Logo









Novostia

Novostia

Private
EpalingesHealthcare & Life Scienceshttps://novostia.com

Last Round

VC Round

Sep 17, 2024

Total Funding Raised

$5.45M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Novostia operates in Healthcare & Life Sciences and is based in Epalinges. Its latest recorded funding round was a VC Round in September 2024.

Novostia SA is a medical device company developing an innovative artificial heart valve designed to not require lifelong anticoagulant medication.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Novostia Comparables

Compare Novostia with similar companies based on industry and business-model similarity.

Novostia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Foldax Inc.
86%
LevTech Lifesciences
86%
Thubrikar Aortic Valve, Inc.
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Novostia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 17, 2024
Series AMay 2, 2023
GrantJan 14, 2020
VC RoundFeb 22, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Novostia Investors

Notable investors and investment history

Novostia investors
InvestorRounds
European Innovation Council FundGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 13, 2026

    Monthly visitors grew 228% MoM, reaching 1.4K.

  • Jun 25, 2026

    Web traffic grew 115% MoM (from 313 to 673 monthly visitors)

Book a demo to see all signals

For institutional investors. Book with your work email.

Novostia Filings

Explore SEC and related filing metadata, where available.

Novostia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Novostia's valuation, stock price, and market status.

Is Novostia a public or private company?

Novostia is a private company.

What is the current stock price of Novostia?

Novostia is a private company, so its shares have no public market price. Caplight tracks Novostia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Novostia worth (valuation)?

Valuation information for Novostia is not publicly available.

Can I buy Novostia stock?

Novostia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Novostia's last funding round?

Novostia's most recent funding round was VC Round on September 17, 2024.

Who are the main investors in Novostia?

Key investors in Novostia include European Innovation Council Fund.

Will Novostia IPO soon?

No public IPO plans have been announced for Novostia.

How can I track Novostia secondary market activity?

Caplight tracks bids, offers, and trades in Novostia's shares on secondary markets.

Firmographic Details

HeadquartersEpalinges
Employee Range6
Year Founded2017
Last FundingSep 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?